Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its…
Read More »COVIDflu
Two might be better than one: A new vaccine that targets the viruses behind seasonal flu and COVID-19 triggers a…
Read More »